CNBX — CNBX Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $0.00m
- $1.36m
- $0.13m
Annual cashflow statement for CNBX Pharmaceuticals, fiscal year end - August 31st, USD millions except per share, conversion factor applied.
2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | 2024 August 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.47 | -3.19 | -3.72 | -3.71 | -0.695 |
| Depreciation | |||||
| Non-Cash Items | 4.33 | 0.545 | 1.44 | 2.96 | 0.245 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.148 | -0.064 | 0.407 | 0.474 | 0.133 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -2.77 | -2.49 | -1.68 | -0.113 | -0.244 |
| Capital Expenditures | -0.076 | -0.001 | -0.002 | 0 | -0.001 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 3.36 | 0.646 | 0.027 | 0.025 | 0.115 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | 3.29 | 0.645 | 0.025 | 0.025 | 0.113 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 2.46 | 0.39 | 0.1 | 0.028 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.512 | 0.609 | -1.27 | 0.012 | -0.103 |